If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
But the science of DNA-based drugs was on the experimental fringe of the biopharma landscape. Not too many investors were looking to make such a bet. Then the COVID-19 pandemic materialized. As it turns out, the coronavirus was the ideal target for Moderna's biotechnology . In December 2020, the U.S. Food and Drug Administration approved its COVID vaccine for emergency use. Other nations' regulatory bodies followed suit. The rest, as they say, is history. Pandemic-prompted gains For the record, the market was already pushing Moderna shares higher before its COVID-19 vaccine was first approved. Shares nearly quintupled in calendar 2020, and ultimately rallied nearly 500% from 2019's low to their 2021 peak. As might have been expected though, the effective end of the pandemic led to the deflation of bullish interest in this stock. Moderna shares are now valued at a mere one-fourth of their 2021 high. Nevertheless, had you taken a flier on this quirky biopharma company's stock
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Does AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy? [Yahoo! Finance]Yahoo! Finance
- Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech [Yahoo! Finance]Yahoo! Finance
- Moderna vaccine patent upheld by European Patent Office: report [Seeking Alpha]Seeking Alpha
- Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at Evercore ISI to a "hold" rating.MarketBeat
MRNA
Earnings
- 5/2/24 - Beat
MRNA
Sec Filings
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- 5/15/24 - Form 144
- MRNA's page on the SEC website